rs750693623
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001182.5(ALDH7A1):c.34del(p.Ala12LeufsTer31) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000108 in 1,555,320 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A12A) has been classified as Likely benign.
Frequency
Consequence
NM_001182.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALDH7A1 | NM_001182.5 | c.34del | p.Ala12LeufsTer31 | frameshift_variant | 1/18 | ENST00000409134.8 | |
ALDH7A1 | NM_001202404.2 | c.34del | p.Ala12LeufsTer31 | frameshift_variant | 1/16 | ||
ALDH7A1 | NM_001201377.2 | c.-51del | 5_prime_UTR_variant | 1/18 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALDH7A1 | ENST00000409134.8 | c.34del | p.Ala12LeufsTer31 | frameshift_variant | 1/18 | 1 | NM_001182.5 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.000532 AC: 81AN: 152230Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000112 AC: 18AN: 160236Hom.: 0 AF XY: 0.0000945 AC XY: 8AN XY: 84674
GnomAD4 exome AF: 0.0000627 AC: 88AN: 1402972Hom.: 0 Cov.: 32 AF XY: 0.0000650 AC XY: 45AN XY: 692492
GnomAD4 genome ? AF: 0.000525 AC: 80AN: 152348Hom.: 0 Cov.: 31 AF XY: 0.000524 AC XY: 39AN XY: 74496
ClinVar
Submissions by phenotype
Pyridoxine-dependent epilepsy Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 01, 2022 | This sequence change creates a premature translational stop signal (p.Ala12Leufs*31) in the ALDH7A1 gene. However, it is currently unclear if variants that occur in this region of the gene cause disease. This variant is present in population databases (rs750693623, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with ALDH7A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 372663). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 04, 2022 | Variant summary: ALDH7A1 c.34delG (p.Ala12LeufsX31) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic within ClinVar (e.g. c.328C>T, p.Arg110Ter; c.796C>T, p.Arg266Ter) . The variant allele was found at a frequency of 0.00015 in 191640 control chromosomes (gnomAD). This frequency is not significantly higher than expected for a pathogenic variant in ALDH7A1 causing Pyridoxine-Dependent Epilepsy (0.00015 vs 0.0018), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.34delG in individuals affected with Pyridoxine-Dependent Epilepsy and no experimental evidence demonstrating its impact on protein function have been reported. Four ClinVar submitters have assessed the variant since 2014: three classified the variant as of uncertain significance and one as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2023 | Observed as heterozygous variant in patients with epilepsy in published literature (Truty et al., 2019); Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31440721) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 23, 2018 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | Apr 21, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2022 | The c.34delG variant, located in coding exon 1 of the ALDH7A1 gene, results from a deletion of one nucleotide at nucleotide position 34, causing a translational frameshift with a predicted alternate stop codon (p.A12Lfs*31). The predicted stop codon occurs in the 5’ end of the ALDH7A1 gene. Premature termination codons in the 5’ end of a gene have been reported to escape nonsense-mediated mRNAdecay and/or lead to re-initiation (Rivas et al. Science. 2015 May 8;348(6235):666-9; Lindeboom et al. Nat Genet. 2016 Oct;48(10):1112-8; Rhee et al. Sci Rep. 2017 May 10;7(1):1653). In addition, this variant is located upstream of an alternate in-frame translation initiation codon. Since this may result in expression of a different isoform and the biological contribution of each isoform is not well established, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at